Results 281 to 290 of about 292,810 (343)

Edaravone dexborneol versus placebo on functional outcomes in patients with acute ischaemic stroke undergoing endovascular thrombectomy (TASTE-2): randomised controlled trial.

BMJ
Wang C, Gu H, Huo X, Yuan B, Li S, Xu J, Jiang Y, Jing J, Yao X, Li Z, Long F, Ma Z, Zhuang X, Xu L, Jin Y, Huang W, Zhang Y, Wen J, Wang A, Pan Y, Ye W, Yu W, Cheng A, Wang M, Dong Q, Xu A, Wang N, Yang Y, Meng X, Liu L, Zhao X, Li H, Miao Z, Li Z, Wang Y, TASTE-2 investigators.   +35 more
europepmc   +1 more source

Prophylactic bilateral internal iliac artery balloon occlusion with immediate sheath removal for placenta accreta spectrum. [PDF]

CVIR Endovasc
Kim SJ, Layden N, Fleming S, Hasan Hİ, Bahabri A, Rylance SL, Dulku GS.   +6 more
europepmc   +1 more source

Pain Management in Aneurysmatic Subarachnoid Haemorrhage: A Survey of Nordic Physicians

Acta Anaesthesiologica Scandinavica, Volume 70, Issue 3, March 2026.
ABSTRACT Background Headache caused by aneurysmatic subarachnoid hemorrhage (aSAH) is often severe and may persist long after the ictus. Pharmacological pain management can be challenging due to poor efficacy or adverse effects. Multimodal pharmacotherapy is often required. Lack of guidelines and good quality clinical studies on pain management has led
Hanna Sariola, Maija‐Liisa Kalliomäki, Heikki Kiiski, Essi Raatikainen, Juhana Frösen, Matti Reinikainen, Hanna Savioja, Kirsten Møller, Terhi Lohela, Riikka Takala, Martin Sigurdsson, Luis Romundstad, Stig Dyrskog, Karsten Bülow, Johanna Hästbacka   +14 more
wiley   +1 more source

Low‐Molecular‐Weight Heparin for Adult ICU Patients Who Require Thromboprophylaxis: Protocol for the INCEPT‐Thromboprophylaxis Platform Trial Domain

Acta Anaesthesiologica Scandinavica, Volume 70, Issue 3, March 2026.
ABSTRACT Background Low‐molecular‐weight heparin (LMWH) is recommended for thromboprophylaxis in adult intensive care unit (ICU) patients. Despite its widespread use, there is insufficient evidence on the optimal dose, and there appears to be practice variation.
Ruben Eck, Anders Granholm, Aske Tøgern, Aksel Karl Georg Jensen, Sandra Jonmarker, Fredrik Sjövall, Karina Meijer, Maria Cronhjort, Morten Hylander Møller, Anders Perner, Frederik Keus   +10 more
wiley   +1 more source

MEMS‐Based Magnetoelectric Antennas for Wireless Power Transmission in Brain‐Implantable Devices

Advanced Materials Technologies, Volume 11, Issue 3, 5 February 2026.
Magnetoelectric (ME) antennas allow the minimization of the invasiveness of brain implantable devices, via powering wirelessly systems able to actuate neural tissue. In order to achieve the necessary power efficiency transmission, the choice of the materials and the system assembly is vital.
Laura Mazón‐Maldonado, Jungang Zhang, María Cerezo‐Sánchez, Mahdieh Shojaei Baghini, Roghaieh Parvizi, Hadi Heidari   +5 more
wiley   +1 more source

Acoustic Sensing as a Tool for Brain Tumor Diagnostics

Advanced Sensor Research, Volume 5, Issue 2, February 2026.
Surface acoustic wave (SAW) sensing is used to distinguish non‐neoplastic brain tissue from primary and metastatic tumors based on their acoustic attenuation signatures. Ex vivo human brain samples reveal clear tissue‐specific mechanical profiles, correlating with stiffness and malignancy.
Melanie E. M. Stamp, Friederike Liesche‐Starnecker, Tina Schaller, Peter Baumgarten, Nadine Lilla, Dorothee Mielke, David Collins   +6 more
wiley   +1 more source

Outcomes of Microsurgical Treatment for Unruptured Intracranial Aneurysms: A 7-Year Institutional Review. [PDF]

Neurosurg Pract
Catapano JS, Koester SW, McCann MM, Rhodenhiser EG, Scherschinski L, Eberle AT, Jensen KN, Naik A, Hackett AM, Nico E, Karahalios K, Hartke JN, Winkler EA, Rulney JD, Spetzler RF, Lawton MT.   +15 more
europepmc   +1 more source

CYP2C19 genotype testing for clopidogrel: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI‐PGx)

British Journal of Clinical Pharmacology, Volume 92, Issue 2, Page 329-347, February 2026.
Clopidogrel, an antiplatelet agent, is currently licensed in the United Kingdom for the prevention and treatment of atherothrombotic events in cerebrovascular disease, coronary artery disease and peripheral arterial disease. Clopidogrel requires metabolic activation by the cytochrome P450 enzyme CYP2C19 to be effective.
Cinzia Dello Russo, Iain Frater, Rebecca Kuruvilla, Stefanie Lip, Hannah O'Neill, Kerry Burke, Vicky Chaplin, Alexander S. F. Doney, Salim Elyas, Nicholas Greaves, Sophie Harding, David Hargroves, Judith Hayward, Dyfrig A. Hughes, Tom A. T. Hughes, Sree Kondapally, Patrick Mok, Aaron Peace, Imran Rafi, Simon Ray, Vicky Stinton, Luigi Venetucci, Munir Pirmohamed   +22 more
wiley   +1 more source